ES7S
TEAS SECTION 7 SURRENDER RECEIVED
07/06/2026
Back to search
Official data from USPTO
FERTIN PHARMA VOYE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
07/09/2026
Trademark type
Combined
Nice classes
5
Filing date
12/14/2023
Registration date
03/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Vejle, DK
Examiner
BUSH, KAREN K
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a rectangular background with the stylized wording "VOYE" centered over a semi translucent rectangle with two rounded corners. The stylized wording "FERTIN PHARMA" is in the top left corner of the rectangle. The outline of an oblong oval encompasses the letters "F" and "E" in the word "FERTIN," and the letter "P" in "PHARMA," italicized, is placed directly under the letter "R" in "FERTIN.".
Holders and representatives
Holders
Fertin Pharma A/S
Representatives
Tamar Niv Bessinger Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nicotine gum for use as an aid to stop smoking
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2024
GNRT
NON-FINAL ACTION E-MAILED
07/17/2024
CNRT
NON-FINAL ACTION WRITTEN
07/17/2024
DOCK
ASSIGNED TO EXAMINER
07/15/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/17/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2024
NWAP
NEW APPLICATION ENTERED
12/14/2023
Continuous trademark protection
Get notified about every new filing that threatens FERTIN PHARMA VOYE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.